Title Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection /
Authors Skerniškytė, Jūratė ; Karazijaitė, Emilija ; Deschamps, Julien ; Krasauskas, Renatas ; Armalytė, Julija ; Briandet, Romain ; Sužiedėlienė, Edita
DOI 10.1186/s12866-019-1615-3
Full Text Download
Is Part of BMC Microbiology.. London : BioMed Central Ltd part of Springer Nature. 2019, vol. 19, art. no. 259, p. [1-12].. ISSN 1471-2180
Keywords [eng] Acinetobacter baumannii ; virulence ; vaccine
Abstract [eng] Background: Multidrug resistant Acinetobacter baumannii is one of the major infection agents causing nosocomial pneumonia. Therefore, new therapeutic approaches against this bacterium are needed. Surface-exposed proteins from bacterial pathogens are implicated in a variety of virulence-related traits and are considered as promising candidates for vaccine development. Results: We show in this study that a large Blp1 protein from opportunistic pathogen A. baumannii is encoded in all examined clinical strains of globally spread international clonal lineages I (IC I) and II (IC II). The two blp1 gene variants exhibit lineage-specific distribution profile. By characterization of blp1 deletion mutants and their complementation with blp1 alleles we show that blp1 gene is required for A. baumannii biofilm formation and adhesion to epithelial cells in IC I strain but not in the IC II strain. Nevertheless both alleles are functional in restoring the deficient phenotypes of IC I strain. Moreover, the blp1 gene is required for the establishing of A. baumannii virulence phenotype in nematode and murine infection models. Additionally, we demonstrate that C-terminal 711 amino acid fragment of Blp1 elicits an efficient protection to lethal A. baumannii infection in a murine model using active and passive immunization approaches. Antiserum obtained against Blp1-specific antigen provides opsonophagocytic killing of A. baumannii in vitro. Conclusions: Lineage-specific variants of surface-exposed components of bacterial pathogens complicate the development of new therapeutic approaches. Though we demonstrated different impact of Blp1 variants on adherence of IC I and IC II strains, Blp1-specific antiserum neutralized A. baumannii strains of both clonal lineages. Together with the observed increased survival rate in vaccinated mice these results indicate that A. baumannii Blp1 protein could be considered as a new vaccine candidate.
Published London : BioMed Central Ltd part of Springer Nature
Type Journal article
Language English
Publication date 2019